Screening for Hemoglobinopathies in Pregnant Women

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04029142

Enrollment

1785

Registered

2019-07-23

Start date

2019-07-03

Completion date

2019-09-30

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemoglobinopathies

Keywords

thalassemia, sickle cell anaemia, molecular genetic analysis

Brief summary

This prospective monocentric study project is to identify hemoglobinopathies in pregnant women in order to optimize antenatal care and to investigate the prevalence of hemoglobinopathies in pregnant women in Switzerland.

Interventions

DIAGNOSTIC_TESTReview of routine lab data

Review of routine lab data from pregnant women (first trimester)

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Yes

Inclusion criteria

* pregnant women seen at the Frauenklinik at University Hospital Basel

Exclusion criteria

* pregnant women with already known hemoglobinopathy * refusal of participation

Design outcomes

Primary

Measure	Time frame	Description
identification of hemoglobinopathies	single time point assessment at baseline	identification of hemoglobinopathies by investigating routine lab samples

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026